Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alpha-2b spray versus ribavirin aerosol for acute upper respiratory tract infection in children
ChiCTR1800020373Phase 4Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of interferon alfa-2b and ribavirin in upper respiratory infection (URI) (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Body temperature. Started Dec 2018; status: completed.
02
Drugs
interferon alfa-2bribavirin
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR1800020373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020373.